Showing 20 of 34 recruiting trials for “choroidal-osteoma”
Immune Response to Percutaneous Hepatic Perfusion With Melphalan for Ocular Melanoma Metastatic to the Liver
👨⚕️ Eric Wehrenberg-Klee, MD, Massachusetts General Hospital📍 1 site📅 Started Jan 2026View details ↗
Neoadjuvant Darovasertib in Primary Uveal Melanoma
Phase 2 Combination of Melphalan/HDS Via PHP + Tebentafusp in Treating Metastatic Uveal Melanoma
Clinical Trial of CD40L-augmented TIL for Patients With Advanced Melanoma
Tebentafusp and Roginolisib in Uveal Melanoma to Prolong T-cell Homeostasis
👨⚕️ Anthony Joshua, MBBS PhD FRACP, St Vinents Hospital sydney📍 2 sites📅 Started Dec 2025View details ↗
A Phase 1-1b Study to Evaluate the Safety, Efficacy and Dosimetry of Study Drug A9-3408 in Subjects With Metastatic Melanoma
RecruitingNCT07421739 ↗
Choroidal Melanoma Patient-Reported Outcome Study (CM-PRO) in a Subset of AU-011-301 (CoMpass) Subjects
Tebentafusp-tebn With LDT in Metastatic UM
Neoadjuvant Tebentafusp for Uveal Melanoma
Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma
Neoadjuvant Tebentafusp in Patients With Metastatic Uveal Melanoma
👨⚕️ Josep Maria Piulats, M.D., Ph.D., Institut Catala d'Oncologia (ICO) Hospitalet📍 4 sites📅 Started Jul 2025View details ↗
Adding IL-2 to Tebentafusp to Eradicate Cancer Progression
Adjuvant Quisinostat in High-Risk Uveal Melanoma
A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel
👨⚕️ Iovance Biotherapeutics Study Team, Iovance Biotherapeutics📍 4 sites📅 Started Mar 2025View details ↗
Study of Tebentafusp and Radioembolization in the Treatment of Metastatic Uveal Melanoma
Resistance Exercise in Patients With Ocular Melanoma
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
Adjuvant Tebentafusp in High Risk Ocular Melanoma
👨⚕️ Paul Nathan, Mount Vernon Cancer Centre, Northwood, UK📍 14 sites📅 Started Nov 2024View details ↗
Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma
Identification of New Candidate Genes for Hereditary Predisposition to Uveal Melanoma
Page 1 of 2Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →